310 related articles for article (PubMed ID: 16731846)
1. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.
Stegenga ME; van der Crabben SN; Levi M; de Vos AF; Tanck MW; Sauerwein HP; van der Poll T
Diabetes; 2006 Jun; 55(6):1807-12. PubMed ID: 16731846
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans.
Blümer RM; van der Crabben SN; Stegenga ME; Tanck MW; Ackermans MT; Endert E; van der Poll T; Sauerwein HP
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E613-7. PubMed ID: 18577692
[TBL] [Abstract][Full Text] [Related]
3. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.
Pandolfi A; Giaccari A; Cilli C; Alberta MM; Morviducci L; De Filippis EA; Buongiorno A; Pellegrini G; Capani F; Consoli A
Acta Diabetol; 2001; 38(2):71-6. PubMed ID: 11757804
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.
Stegenga ME; van der Crabben SN; Blümer RM; Levi M; Meijers JC; Serlie MJ; Tanck MW; Sauerwein HP; van der Poll T
Blood; 2008 Jul; 112(1):82-9. PubMed ID: 18316629
[TBL] [Abstract][Full Text] [Related]
5. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
[TBL] [Abstract][Full Text] [Related]
6. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.
Rao AK; Chouhan V; Chen X; Sun L; Boden G
Diabetes; 1999 May; 48(5):1156-61. PubMed ID: 10331423
[TBL] [Abstract][Full Text] [Related]
7. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction.
Oomen PH; Kant GD; Dullaart RP; Reitsma WD; Smit AJ
Microvasc Res; 2002 Jan; 63(1):1-9. PubMed ID: 11749067
[TBL] [Abstract][Full Text] [Related]
8. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in man.
Landin K; Tengborn L; Smith U
Thromb Haemost; 1994 Jun; 71(6):783-7. PubMed ID: 7974348
[TBL] [Abstract][Full Text] [Related]
10. Association between early glycemic control and improvements in markers of coagulation and fibrinolysis in patients with septic shock-induced stress hyperglycemia.
Sanches LC; Pontes Azevedo LC; Salomão R; Noguti MA; Brunialti M; Lourenço DM; Machado FR
J Crit Care; 2014 Oct; 29(5):884.e1-6. PubMed ID: 24891151
[TBL] [Abstract][Full Text] [Related]
11. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans.
Krogh-Madsen R; Møller K; Dela F; Kronborg G; Jauffred S; Pedersen BK
Am J Physiol Endocrinol Metab; 2004 May; 286(5):E766-72. PubMed ID: 14722028
[TBL] [Abstract][Full Text] [Related]
12. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
13. Assessment of insulin resistance in newborn beagles with the euglycemic hyperinsulinemic clamp.
Hulman SE; Kliegman RM
Pediatr Res; 1989 Feb; 25(2):219-23. PubMed ID: 2645563
[TBL] [Abstract][Full Text] [Related]
14. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
15. Insulin decreases human adiponectin plasma levels.
Möhlig M; Wegewitz U; Osterhoff M; Isken F; Ristow M; Pfeiffer AF; Spranger J
Horm Metab Res; 2002; 34(11-12):655-8. PubMed ID: 12660877
[TBL] [Abstract][Full Text] [Related]
16. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects.
Calles-Escandon J; Mirza SA; Sobel BE; Schneider DJ
Diabetes; 1998 Feb; 47(2):290-3. PubMed ID: 9519730
[TBL] [Abstract][Full Text] [Related]
17. Effects of hyperinsulinemia and hyperglycemia on lactate release and local blood flow in subcutaneous adipose tissue of healthy humans.
Henry S; Schneiter P; Jéquier E; Tappy L
J Clin Endocrinol Metab; 1996 Aug; 81(8):2891-5. PubMed ID: 8768847
[TBL] [Abstract][Full Text] [Related]
18. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
19. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
